Text Size: a  |   a 

Pharmacist-Led Program May Improve MS Treatment Adherence

June 12, 2017

Wing Loong Cheong, MPharm, MBA, from Monash University in Subang Jaya, Malaysia, describes a pharmacist medication adherence program for patients with RRMS using INF-β. It is established in order to improve patient adherence to treatment and provide education on RRMS and INF-β. Twenty-seven patients were enrolled into the 26-month program. Pharmacists conducted assessments of adherence to INF-β, knowledge, and symptoms and disability experienced at the initial enrollment and during each visit. According to the results, there was only one patient that was non-adherent and an increase in patient knowledge scores.

"We are encouraged by the high degree of patient adherence to treatment observed in this program and the improvements observed in the patients' knowledge of RRMS and INF-β," Dr Cheong writes. "We look forward to conducting future studies using controlled groups to establish the effect of such a program on patient treatment adherence and to establish the link between patient knowledge and treatment adherence."

Via Neurology Advisor